Recombinant DNA - PDFSEARCH.IO - Document Search Engine

Recombinant DNA
Results: 832

#	Item
401	Human Papillomavirus Immunotherapy and the Vaccine Exemption Under NIH Guidelines Recombinant DNA Advisory Committee Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-31 14:29:11 Microbiology HPV vaccine Human papillomavirus Cervical intraepithelial neoplasia Cervical cancer Vaccine Papillomaviridae Cervix HspE7 Papillomavirus Medicine Biology
402	GTSAB REPORT Recombinant DNA Advisory Committee September 9, 2009 Protocols Submitted for Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-06 12:30:07 Regulatory T cell T helper cell Ovarian cancer Zinc finger Biology T cells H19
403	RECOMBINANT DNA ADVISORY COMMITTEE JUNE 11, 2013 A PHASE I/II, OPEN-LABEL DOSE ESCALATION STUDY TO EVALUATE THE SAFETY AND EFFICACY OF SINGLE DOSES OF TT-034 IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) INFECTION Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 12:03:53 RNA Viral structural proteins Small hairpin RNA RNA interference E1 NS2 NS4 NS5 E2 Biology Genetics Viral nonstructural proteins
404	Serious and Other Selected Adverse Events Reported for Human Gene Transfer Protocols Recombinant DNA Advisory Commitee Meeting March 2004 Protocol Number: Protocol Title: Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-16 11:18:45 Chemotherapy Oncology Granulocyte macrophage colony-stimulating factor Cancer vaccine Osteosarcoma Medicine Biology Cancer treatments
405	SERIOUS, POSSIBLY ASSOCIATED AND UNEXPECTED ADVERSE EVENTS REPORTED FOR HUMAN GENE TRANSFER PROTOCOLS REPORTING PERIOD: [removed]01 RECOMBINANT DNA ADVISORY COMMITTEE MEETING March 2001 Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-10 13:00:23 Clinical research Design of experiments Kidney cancer Clinical trial Pharmaceutical industry Pharmacology Melanoma Gene therapy Renal cell carcinoma Medicine Biology Science
406	SAFETY REPORTS AND ADVERSE EVENTS FOR HUMAN GENE TRANSFER PROTOCOLS RECOMBINANT DNA ADVISORY COMMITTEE MEETING December 13 and 15, 2000 ID # Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-10 12:51:55 Chemotherapy Ovarian cancer Design of experiments Medicine Melanoma Lung cancer
407	RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting March 15, 2006 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 14:31:52 Biotechnology Molecular genetics DNA Viral vector Vector DNA vaccination Recombinant DNA Lentivirus Feline immunodeficiency virus Biology Molecular biology Gene delivery
408	Recombinant DNA Advisory Committee Meeting June 8-9, 2004 Discussion of Human Gene Transfer Protocol #[removed]entitled: A phase I open label, non-randomized, dose-escalation, multi-center, therapeutic trial of the safet Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-16 11:42:16 Immunology Ras subfamily Carcinogenesis Immunotherapy Medicine Oncology KRAS
409	Monitoring and Oversight of NIH-Funded Research MONITORING and OVERSIGHT of NIH-FUNDED RESEARCH: Institutional Responsibilities NIH Extramural Research Program NIH Office of Biotechnology Activities (OBA) CDC/DSAT (HHS S Add to Reading List Source URL: grants.nih.gov Language: English - Date: 2014-10-03 09:31:45 Cancer research Nursing research Health Medical research Recombinant DNA National Institutes of Health Medicine Bethesda Maryland
410	National Institutes of Health Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-24 13:30:36 Biosecurity United States Department of Health and Human Services Synthetic biology National Institutes of Health Recombinant DNA Artificial gene synthesis Nucleic acid Select agent Dual-use technology Biology Molecular genetics Biotechnology

UPDATE